(Q42824817)

8 November 2017

A novel splice variant of HER2 with increased transformation activity (English)

1 reference

8 November 2017

Kwong KY

1

1 reference

PubMed ID

9808159

8 November 2017

Hung MC

series ordinal

2

1 reference

PubMed ID

9808159

8 November 2017

language of work or name

1 reference

1 October 1998

1 reference

8 November 2017

Molecular Carcinogenesis

1 reference

8 November 2017

23

1 reference

8 November 2017

62-68

1 reference

8 November 2017

2

1 reference

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

8 November 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

Absence of activating mutations in the transmembrane domain of the c-erbB-2 protooncogene in human lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

Mutations affecting conserved cysteine residues within the extracellular domain of Neu promote receptor dimerization and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

Requirement for neuregulin receptor erbB2 in neural and cardiac development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

Stage- and tissue-specific expression of the neu oncogene in rat development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2744%28199810%2923%3A2%3C62%3A%3AAID-MC2%3E3.0.CO%3B2-O

10.1002/(SICI)1098-2744(199810)23:2<62::AID-MC2>3.0.CO;2-O

21 January 2018

Identifiers

DOI

1 reference

8 November 2017

1 reference

PubMed ID

9808159